群体药动学模型选择对新生儿万古霉素初始给药方案影响的模拟研究
该模拟研究基于虚拟新生儿人群,使用26个既往经外部评估的万古霉素群体药动学模型模拟5种给药方案,评估各模型推荐最优初始剂量的—致性及预测性能对目标达成概率(PTA)的影响。多数模型(15/26)对最优给药方案达成一致,先验预测性能最佳者PTA最高;多元回归显示不精确度(P=.048)而非偏倚(P=.469)显著影响PTA,调整R²为.21。
要点
- 多数万古霉素popPK模型对新生儿最优初始剂量推荐一致。
- 先验预测性能更优的模型可获得更高的目标达成概率。
- 模型不精确度而非偏倚显著影响PTA,但仅解释小部分变异。
核心结论
- 尽管各模型偏倚与不精确度存在差异,多数模型对新生儿万古霉素初始最优剂量达成共识。
- 先验预测性能更优的模型产生更高的PTA值。
- 偏倚和不精确度仅能预测PTA变异的一小部分,其中不精确度影响更明显。
研究设计与样本
- 模拟研究:构建虚拟新生儿患者人群,使用26个既往经外部评估的万古霉素群体药动学模型模拟5种给药方案。
- 对每个模拟场景计算AUC和PTA,评估26个模型间最优初始剂量的一致性。
- 采用多元回归分析模型预测性能对PTA的影响。
主要发现
- 15/26个模型对最优给药方案达成一致。
- 先验预测性能最佳的模型获得最高PTA。
- 多元回归显著预测平均ln转换PTA:F(2, 23)=5.406,P=.010,调整R²=.21。
- PTA受不精确度显著影响(P=.048),偏倚影响不显著(P=.469)。
临床怎么用
- 新生儿万古霉素初始剂量选择可参考多数模型共识的最优方案。
- 优先选用先验预测性能更优的popPK模型以获更高PTA。
局限性
- 偏倚和不精确度仅解释PTA变异的小部分(调整R²=.21)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The accuracy of model-informed precision dosing largely depends on selecting the most appropriate population pharmacokinetic (popPK) model from many available options. This study aims to evaluate the concordance of optimal initial simulated doses among various vancomycin popPK models developed in neonates and to explore the role of predictive performance in explaining the variability in probability of target attainment (PTA). METHODS: A virtual neonatal patient population was created and 26 previously externally evaluated vancomycin popPK models were used to simulate 5 different dosing regimens. For each simulated scenario, the area under the concentration-time curve and PTA were calculated to assess the agreement on optimal initial doses across the 26 models. A multiple regression was performed to explore the impact of the models' predictive performance on PTA. RESULTS: For most models (15/26), there was an agreement on the optimal dosing regimen. The highest PTA being achieved by the model with the best a priori predictive performance. The multiple regression model significantly predicted mean ln-transformed PTA, with F(2, 23) = 5.406 and P = .010, yielding an adjusted R2 of .21. PTA was significantly influenced by imprecision (P = .048) but not bias (P = .469). CONCLUSION: In conclusion, our study demonstrated that, despite the variability in bias and imprecision, there was a consensus on the initial optimal doses for the majority of models; however, models with superior a priori predictive performance yielded higher PTA values. Bias and imprecision alone only seem to predict a small proportion of the variability in PTA, with imprecision having a more pronounced effect.
引用
- El Hassani M, Blouin M, Marsot A, et al. A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates. Br J Clin Pharmacol. 2024. PMID: 39628279. doi:10.1111/bcp.16345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。